Literature DB >> 8831149

Quantitative measurement of 3-O-methyl-D-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo.

F Shojaee-Moradie1, N C Jackson, R H Jones, A I Mallet, R Hovorka, A M Umpleby.   

Abstract

Existing methods of measuring glucose kinetics are subject to errors. There is considerable interest in improved methods of measuring glucose kinetics to allow the development of new regimes for the treatment of diabetes mellitus. 3-O-Methyl-D-glucose is transported but not metabolized and therefore allows independent estimation of transport parameters. We describe a method by which 3-O-methyl-D-glucose in plasma samples can be measured in protocols during which glucose flux is assessed with simultaneous use of two isotopically labeled glucoses to quantitate and validate measurements of the rate of glucose appearance and disappearance. Quantitative gas chromatographic/mass spectrometric (GC/MS) analysis of 3-O-methyl-D-glucose, D-glucose, D-[U-13C] glucose and D-[6,6-2H2] glucose in human plasma using methoxime-trimethylsilyl ether derivatives is described. Measurements of all four derivatives were performed together in a small sample volume (50 microliters) with high precision. The intra-assay (inter-assay) coefficients of variation at an isotope content of 0.25 atom% excess for D-[6,6-2H2] glucose, D-[U-13C] glucose and 3-O-methyl-D-glucose were 0.8% (1.0%), 0.5% (4.0%) and 0.1% (3.7%), respectively. This method provides the basis for quantitative estimation of parameters of glucose kinetics in man and the rates of glucose flux across the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831149     DOI: 10.1002/(SICI)1096-9888(199609)31:9<961::AID-JMS359>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  12 in total

1.  Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.

Authors:  D Elleri; J M Allen; J Harris; K Kumareswaran; M Nodale; L Leelarathna; C L Acerini; A Haidar; M E Wilinska; N Jackson; A M Umpleby; M L Evans; D B Dunger; R Hovorka
Journal:  Diabetologia       Date:  2013-02-23       Impact factor: 10.122

2.  Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp.

Authors:  S V M Hordern; J E Wright; A M Umpleby; F Shojaee-Moradie; J Amiss; D L Russell-Jones
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

3.  The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus.

Authors:  R M Williams; R Amin; F Shojaee-Moradie; A M Umpleby; C L Acerini; D B Dunger
Journal:  Diabetologia       Date:  2003-07-24       Impact factor: 10.122

4.  Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy.

Authors:  H R Murphy; D Elleri; J M Allen; J Harris; D Simmons; G Rayman; R C Temple; A M Umpleby; D B Dunger; A Haidar; M Nodale; M E Wilinska; R Hovorka
Journal:  Diabetologia       Date:  2011-11-12       Impact factor: 10.122

5.  Validity of triple- and dual-tracer techniques to estimate glucose appearance.

Authors:  A Haidar; D Elleri; J M Allen; J Harris; K Kumareswaran; M Nodale; C L Acerini; M E Wilinska; N Jackson; A M Umpleby; M L Evans; D B Dunger; R Hovorka
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

6.  Efficacy of increased resistant starch consumption in human type 2 diabetes.

Authors:  C L Bodinham; L Smith; E L Thomas; J D Bell; J R Swann; A Costabile; D Russell-Jones; A M Umpleby; M D Robertson
Journal:  Endocr Connect       Date:  2014-04-15       Impact factor: 3.335

7.  Intracerebroventricular Catalase Reduces Hepatic Insulin Sensitivity and Increases Responses to Hypoglycemia in Rats.

Authors:  S Pauliina Markkula; David Lyons; Chen-Yu Yueh; Christine Riches; Paul Hurst; Barbara Fielding; Lora K Heisler; Mark L Evans
Journal:  Endocrinology       Date:  2016-10-14       Impact factor: 4.736

8.  Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study.

Authors:  L Hodson; L Bhatia; E Scorletti; D E Smith; N C Jackson; F Shojaee-Moradie; M Umpleby; P C Calder; C D Byrne
Journal:  Eur J Clin Nutr       Date:  2017-03-15       Impact factor: 4.016

9.  Black African men with early type 2 diabetes have similar muscle, liver and adipose tissue insulin sensitivity to white European men despite lower visceral fat.

Authors:  Oluwatoyosi Bello; Cynthia Mohandas; Fariba Shojee-Moradie; Nicola Jackson; Olah Hakim; K George M M Alberti; Janet L Peacock; A Margot Umpleby; Stephanie A Amiel; Louise M Goff
Journal:  Diabetologia       Date:  2019-02-06       Impact factor: 10.122

10.  Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism.

Authors:  F Shojaee-Moradie; K C R Baynes; C Pentecost; J D Bell; E L Thomas; N C Jackson; M Stolinski; M Whyte; D Lovell; S B Bowes; J Gibney; R H Jones; A M Umpleby
Journal:  Diabetologia       Date:  2006-12-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.